Tasimelteon Approved for Treatment of Non-24 Sleep Wake Disorder0

In 2014, the Food and Drug Administration (FDA) approved the medication tasimelteon (found under the brand name Hetlioz) for the treatment of Non 24-Hour Sleep Wake Disorder (Non-24) in blind individuals.

FREE REPORT
"Learn How To Improve Your Sleeping Patterns and Get Deeper Into Sleep"
Put your best email below to receive instant access to report now!
Leave a Reply